XML 127 R113.htm IDEA: XBRL DOCUMENT v3.8.0.1
Shareholders' Equity - Summary of Restricted Stock Units (Details) - $ / shares
shares in Millions
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Nov. 30, 2015
Restricted Stock, Service-Based      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Restricted Stock, Outstanding, Beginning Balance (in shares) 0.6    
Restricted Stock, Granted (in shares) 0.1    
Restricted Stock, Vested (in shares) (0.3)    
Restricted Stock, Outstanding, Ending Balance (in shares) 0.4 0.6  
Restricted Stock, Expected to vest (in shares) 0.4    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted Average Grant Date Fair Value, Beginning Balance (in USD per share) $ 18.06    
Weighted Average Grant Date Fair Value, Granted (in USD per share) 24.98 $ 17.65 $ 20.70
Weighted Average Grant Date Fair Value, Vested (in USD per share) 18.12    
Weighted Average Grant Date Fair Value, Ending Balance (in USD per share) 20.14 $ 18.06  
Weighted Average Grant Date Fair Value, Expected to vest (in USD per share) $ 20.14    
Performance-Based Restricted Stock      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Restricted Stock, Outstanding, Beginning Balance (in shares) 1.1    
Restricted Stock, Granted (in shares) 0.5    
Restricted Stock, Vested (in shares) (0.3)    
Restricted Stock, Canceled (in shares) (0.3)    
Restricted Stock, Outstanding, Ending Balance (in shares) 1.0 1.1  
Restricted Stock, Expected to vest (in shares) 0.6    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted Average Grant Date Fair Value, Beginning Balance (in USD per share) $ 17.85    
Weighted Average Grant Date Fair Value, Granted (in USD per share) 22.35 $ 15.97 $ 21.33
Weighted Average Grant Date Fair Value, Vested (in USD per share) 15.80    
Weighted Average Grant Date Fair Value, Canceled (in USD per share) 18.48    
Weighted Average Grant Date Fair Value, Ending Balance (in USD per share) 19.73 $ 17.85  
Weighted Average Grant Date Fair Value, Expected to vest (in USD per share) $ 19.74